Emergency Medicine
Found 5 companies.
🏢 Entrada Therapeutics
👥 101-250💰 $100,000,000 Post-IPO Equity 9 months agoBiotechnologyEmergency MedicineMedicalHealth CareGenetics💼 Private Company
Website LinkedIn Email

Entrada Therapeutics is a clinical-stage biopharmaceutical company pioneering a novel approach to treating devastating diseases. We develop Endosomal Escape Vehicle (EEV™) therapeutics, designed for efficient intracellular delivery of proteins, peptides, and nucleic acids, overcoming limitations of traditional large and small molecule therapies. This innovative technology allows us to target previously inaccessible intracellular pathways, advancing a robust portfolio of RNA-, antibody-, and enzyme-based programs for neuromuscular, ocular, metabolic, and immunological diseases. Our lead oligonucleotide programs are in development for Duchenne muscular dystrophy, and we've partnered on a clinical-stage program for myotonic dystrophy type 1. Entrada operates with a strong tech foundation, utilizing technologies such as Drupal 10, Akamai EdgeWorkers, and BunnyCDN Header for our web infrastructure and various other technologies for streamlining internal processes. Our engineering culture fosters collaboration and innovation, valuing a balance between cutting-edge technology and patient-focused results. We pride ourselves on our values of Humanity, Tenacity, Creativity, Collaboration, and Curiosity – these principles guide our work and interactions. We're a dynamic team of experts in therapeutic development and rare diseases, currently employing 101-250 people and headquartered in Boston, MA. With significant funding secured and a growing pipeline of promising therapies, Entrada is poised for continued growth and expansion. We offer a variety of remote work opportunities and employee benefits designed to support a positive work-life balance. Entrada is an equal opportunity employer committed to fostering a diverse and inclusive workplace. We encourage candidates from all backgrounds to apply.

🏢 SERB Pharmaceuticals
👥 251-500PharmaceuticalEmergency MedicineMedicalManufacturingHealth Care
Website LinkedIn Email

SERB Pharmaceuticals is a specialty pharmaceutical company that focuses on the treatment of patients with critical conditions. The company's primary focus is on emergency care and rare diseases. SERB Pharmaceuticals is a combination of SERB, BTG Specialty Pharmaceuticals, and Veriton Pharma, forming a growing specialty pharmaceutical entity. The company also aims to build up management systems that match global practices in the promotion and funding of basic research. They have developed a scheme called SERB-SUPRA for scientific and useful profound research, including drug discovery and the study of chemical toxicity.

🏢 Norton Healthcare
Women'sEmergency MedicinemHealthNon ProfitHospitalInformation TechnologyHealth CareLGBTOutpatient Care
Website LinkedIn Facebook Twitter

Norton Healthcare is a leading healthcare provider with a strong faith heritage, dedicated to delivering quality care to patients in the Greater Louisville area and beyond.

🏢 Abbott
👥 1001-5000💰 $100,000 Post-IPO Debt about 14 years ago🫂 Last layoff over 3 years agoPharmaceuticalBiotechnologyEmergency MedicineNutritionMedicalMedical DeviceManufacturingHealth CareGeneticsHealth Diagnostics
Website LinkedIn Email Facebook Twitter

Abbott is engaged in pharmaceuticals and manufacturing healthcare products. It developed the first HIV blood-screening test. Its product portfolio includes Norvir, a treatment for HIV; Synthroid, a synthetic thyroid hormone; Depakote, an anticonvulsant drug; and Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and more.

🏢 ZipLiens
👥 11-50💰 Corporate over 1 year agoEmergency MedicineConsultingMedical💼 Private Company
Website LinkedIn Email Facebook

ZipLiens streamlines lien resolution for personal injury law firms, leveraging technology to transform a complex process into a streamlined, efficient one. We're a leading provider in the legal tech space, improving client outcomes and freeing up valuable time for law firms. Our tech stack includes technologies such as Viewport Meta, iPhone/Mobile compatibility, Content Delivery Network, Amazon Web Services, and various other tools. We prioritize efficiency and collaboration, fostering a supportive and innovative work environment. Our mission is to empower law firms to achieve maximum productivity, and we're passionate about delivering exceptional results. ZipLiens is a growing company, having received funding in 2023, and we're committed to further developing our technology and expanding our reach within the legal industry. Our team uses a blend of cutting-edge technology and deep industry expertise to manage and reduce medical liens, Medicare and Medicaid liens, ERISA liens, and hospital liens. This process leads to significant cost savings and increased efficiency for our clients. We are constantly exploring and adopting new technologies to enhance our service offerings and remain at the forefront of lien resolution. Our commitment to client success and continuous improvement defines our company culture. ZipLiens offers a stimulating work environment for individuals who thrive in a fast-paced, technology-driven setting. We value collaboration, innovation, and a commitment to excellence. We are a mid-sized company (11-50 employees) based in Kentucky, offering a competitive benefits package including comprehensive healthcare, 401K matching, and paid time off. Our continued growth demonstrates our commitment to innovation and our positive impact on the legal industry. We're currently seeking talented and ambitious professionals to join our expanding team.